Should chronic obstructive pulmonary disease outpatients be routinely evaluated for trace elements?

Area of Science:

• Clinical Medicine
• Biochemistry
• Pulmonology

Background:

• Chronic Obstructive Pulmonary Disease (COPD) management often involves monitoring various biomarkers.
• Oxidative stress is implicated in COPD pathogenesis, and trace elements play crucial roles in cellular functions and antioxidant defense.

Purpose of the Study:

• To investigate serum trace element concentrations (copper, zinc, magnesium, iron) and their correlation with malondialdehyde (MDA), an oxidative stress marker, in COPD outpatients.
• To determine the necessity of routine trace element evaluation in clinically stable COPD patients.

Main Methods:

• Serum concentrations of copper (Cu), zinc (Zn), magnesium (Mg), and iron (Fe) were measured using atomic absorption spectrophotometry and autoanalyzer.
• Serum malondialdehyde (MDA) levels, as a marker of oxidative stress, were determined spectrophotometrically.
• Statistical analysis was performed to correlate trace elements with MDA and compare levels between COPD patients and controls.

Main Results:

• Serum concentrations of Cu, Zn, Mg, Fe, and MDA were within normal reference ranges for both COPD patients and controls.
• No significant correlation was found between MDA and the measured trace elements (Cu, Zn, Mg, Fe).
• COPD patients showed significantly lower serum Zn (p=0.042) and higher serum Mg (p=0.021) compared to controls, but these were not indicative of deficiency or increased oxidative stress.

Conclusions:

• Clinically stable, regularly treated COPD outpatients do not exhibit increased oxidative stress.
• Routine monitoring of serum trace elements (Cu, Fe, Mg, Zn) is not warranted in this patient population.
• While serum zinc may be near the lower limit of normal, it does not necessitate routine screening in stable COPD.